IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -40.0% | 41,732 | -23.6% | 0.00% | – |
| Q2 2022 | $25,000 | -24.2% | 54,600 | -16.3% | 0.00% | – |
| Q1 2022 | $33,000 | -66.3% | 65,199 | -62.3% | 0.00% | – |
| Q4 2021 | $98,000 | -84.4% | 172,768 | -71.6% | 0.00% | – |
| Q3 2021 | $627,000 | -26.0% | 609,205 | -13.7% | 0.00% | – |
| Q2 2021 | $847,000 | -54.1% | 705,620 | -50.3% | 0.00% | – |
| Q1 2021 | $1,846,000 | +415.6% | 1,419,829 | +1356.8% | 0.00% | – |
| Q4 2020 | $358,000 | +426.5% | 97,462 | +155.6% | 0.00% | – |
| Q2 2020 | $68,000 | -61.8% | 38,137 | -71.8% | 0.00% | – |
| Q1 2020 | $178,000 | +134.2% | 135,085 | +225.2% | 0.00% | – |
| Q4 2019 | $76,000 | -11.6% | 41,542 | +40.4% | 0.00% | – |
| Q3 2019 | $86,000 | -66.4% | 29,585 | -69.0% | 0.00% | – |
| Q2 2019 | $256,000 | +333.9% | 95,369 | +306.8% | 0.00% | – |
| Q1 2019 | $59,000 | +110.7% | 23,444 | +131.8% | 0.00% | – |
| Q4 2018 | $28,000 | -80.7% | 10,115 | -37.7% | 0.00% | – |
| Q3 2018 | $145,000 | – | 16,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $68,000 | 0.23% |
| Virtu Financial LLC | 325,330 | $390,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 141,000 | $169,000 | 0.02% |
| Clear Creek Financial Management, LLC | 49,696 | $60,000 | 0.01% |
| Palo Alto Investors LP | 77,044 | $92,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 738,620 | $886,000 | 0.00% |
| MARSHALL WACE, LLP | 477,449 | $573,000 | 0.00% |
| WADE G W & INC | 35,000 | $42,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 599,471 | $719,000 | 0.00% |
| BRYN MAWR TRUST Co | 33,892 | $41,000 | 0.00% |